IndiaTickerLatest filing: Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Newspaper Publication
ObservedCompany dossier
Aurobindo Pharma
NSE:AUROPHARMA · ISIN INE406A01037
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Aurobindo Pharma
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Mar 2026 · revenue ₹8,853.3 Cr · PAT ₹920.8 Cr.
Exchange XBRLLatest ownership: promoter group 51.88% and public 48.12% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE · exchange filing
Observed
Source filing Copy of Newspaper Publication - Aurobindo Pharma Limited
NSE · exchange filing
Observed
Source filing General Updates - Aurobindo Pharma Limited
NSE · exchange filing
Observed
Source filing Aurobindo Pharma Ltd - 524804 - Intimation Of 39Th Annual General Meeting Of Aurobindo Pharma Limited.
BSE · exchange filing
Reported financials
Full financials →31 Mar 2026
- Revenue from operations
- ₹8,853.3 Cr
- Profit after tax
- ₹920.8 Cr
- EPS
- ₹15.86
Observed BSE structured filing · consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 51.88%
- Public
- 48.12%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL